SCHEMBL24397156

SCHEMBL24397156

COc1ccc(/C(=N\O)c2ccccc2)c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 3/20 0.51
▸ MGLL Q99685 2/20 0.51
▸ PLK1 P53350 1/20 0.50
▸ MAPT P10636 3/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ HPGDS O60760 1/20 0.49
▸ HTT P42858 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ STAT6 P42226 1/20 0.44
▸ IDO1 P14902 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24292234 0.82 CDC25B (0.54) CDC25BPLK1MAPTKMT2AHPGD
SCHEMBL3958758 0.80 KDM4E (0.52) MGLLMAPTKMT2AHPGDHTT
SCHEMBL14537714 0.80 HPGDS (0.58) CDC25BPLK1MAPTKMT2AHPGD
SCHEMBL24397526 0.79 CDC25B (0.54) CDC25BPLK1MAPTKMT2AHPGD
SCHEMBL14836952 0.79 CDC25B (0.54) CDC25BPLK1MAPTKMT2AHPGD
SCHEMBL13234903 0.77 GAA (0.54) CDC25BPLK1MAPTKMT2AHPGD
SCHEMBL2949654 0.77 GAA (0.54) CDC25BPLK1MAPTKMT2AHPGD
SCHEMBL6250609 0.77 MAPT (0.77) CDC25BPLK1MAPTKMT2AHPGD
SCHEMBL24396840 0.77 CDC25B (0.45) CDC25BPLK1MAPTKMT2AHPGD
SCHEMBL10596916 0.75 MGLL (0.60) MGLLMAPTKMT2AHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220137507-A1 COMPOUND, ACID GENERATOR, COMPOSITION, CURED PRODUCT, CURED PRODUCT MANUFACTURING METHOD, AND PATTERN COATING MANUFACTURING METHOD ADEKA CORPORATION (JP) 2022-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220137507-A1 COMPOUND, ACID GENERATOR, COMPOSITION, CURED PRODUCT, CURED PRODUCT MANUFACTURING METHOD, AND PATTERN COATING MANUFACTURING METHOD H1-0, H1-4, HRH1 CDC25B 2515/4885MGLL 3641/4885PLK1 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback